The IRS released Revenue Procedure 2025-28 on August 28, 2025, providing crucial guidance on how businesses should handle research and development (R&D) expenses under the One Big Beautiful Bill Act (OBBBA). This guidance creates immediate tax planning opportunities and affects returns due on September 15 and October 15, 2025.
If your business invests in R&D activities, these new rules could significantly impact your tax liability and generate refunds for prior years. Here’s what you need to know.
The OBBBA fundamentally changed how businesses treat R&D expenses, creating separate rules for domestic and foreign research activities.
Starting with tax years beginning after December 31, 2024, businesses can now deduct domestic R&D expenses immediately under the new Section 174A. This represents a significant shift from the Tax Cuts and Jobs Act (TCJA), which required these expenses to be capitalized and amortized over a five-year period.
Alternatively, businesses can elect to continue capitalizing and amortizing domestic R&D expenses over 60 months, for tax years begining after December 31, 2024.
Foreign R&D expenses continue to be capitalized and amortized over 15 years.
The new guidance provides options for handling R&D expenses that were capitalized under the TCJA between 2022 and 2024.
Any taxpayer can elect to handle remaining unamortized domestic R&D amounts from 2022-2024 by either:
The guidance also allows eligible small businesses to:
These changes can optimize the relationship between R&D deductions and credits, potentially maximizing overall tax benefits.
For the first tax year beginning after December 31, 2024, the Form 3115 requirement is waived, and a statement in lieu of Form 3115 is authorized.
Small businesses meeting specific criteria have access to particularly favorable treatment under the new guidance.
You’re considered an eligible small business if you:
Eligible small businesses can apply the new Section 174A rules retroactively to tax years 2022-2024. This means you can potentially:
The election can be made by:
Critical deadline: Elections on AAR or amended returns must be filed by the earlier of July 6, 2026, or the statute of limitations deadline for refund claims.
Small businesses filing original/superseded returns on or before November 15, 2025, will be deemed to have made the election if they deduct domestic R&D expenses on the return and meet other requirements.
If you are making a deemed election in 2024, you must also amend returns for 2022 and 2023.
Recognizing that many taxpayers filed 2024 returns before this guidance was available, the IRS is granting an automatic six-month extension to file superseding returns to all small business taxpayers.
This applies to eligible entities that:
To use this extension, write “REVENUE PROCEDURE 2025-28” at the top of your superseding return.
This guidance creates significant planning opportunities, particularly for small businesses. Consider these steps:
The complexity of these rules and the tight deadlines make professional guidance essential. Working with a qualified tax advisor can help ensure you maximize the benefits while meeting all compliance requirements.
For additional support or questions, reach out to our team today. We’ll continue to provide updates on these developments.